Indianstockmarket.net is an effort to educate indian investor by providing useful stock news, stock market websites, informative articles, resources to various investment guides.

Wed, 07 May 2008 00:21:19 GMT

Teva seeks judgment on Astra's Nexium patents (Reuters via Yahoo! India News)
LOS ANGELES (Reuters) - Teva Pharmaceutical Industries Ltd has sued AstraZeneca Plc asking for a declaratory judgment on remaining Nexium patents, AstraZeneca said on Tuesday.

Wed, 07 May 2008 12:48:00 GMT

Indian shares fall, pulled down by Bharti Airtel (AP via Yahoo! Philippines News)
Indian shares fell Wednesday, dragged down by telecommunication firm Bharti Airtel.

Wed, 07 May 2008 13:04:06 GMT

Indian shares fall, pulled down by Bharti Airtel (INO News)
(AP:MUMBAI, India) Indian shares fell Wednesday, dragged down by telecommunication firm Bharti Airtel. The Bombay Stock Exchange's benchmark 30-stock Sensex dipped 34 points, or 0.2 percent, to 17,339 points.

Wed, 07 May 2008 16:57:27 GMT

Ion Channel Drug Discovery - Therapeutic Opportunities & Technology Progress (Centre Daily Times)
Research and Markets (http://www.researchandmarkets.com/reportinfo.asp?report_id=74332) has announced the addition of "Ion Channel Drug Discovery - Therapeutic Opportunities & Technology Progress" to their offering.

Wed, 07 May 2008 16:41:00 GMT

Ion Channel Drug Discovery - Therapeutic Opportunities & Technology Progress (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of "Ion Channel Drug Discovery - Therapeutic Opportunities & Technology Progress" to their offering.

Mon, 05 May 2008 11:05:32 GMT

IOL Chemicals sees FY'11 turnover at 8 bln rupees (Reuters via Yahoo! Singapore News)
NEW DELHI, May 5 - IOL Chemicals & Pharmaceuticals Ltd said on Monday it is targeting a turnover of 8 billion rupees by the year ending March 2011, helped by full utilisation of its expanded capacities.

Mon, 05 May 2008 15:46:24 GMT

Sector Snap: Goldman looking for Teva patent suit updates (AP via Yahoo! Finance)
A Goldman Sachs analyst said Monday he expects Teva Pharmaceutical to update investors on its pending patent challenges when the Israeli generic drugmaker reports first-quarter earnings on Tuesday.

Tue, 22 Apr 2008 08:52:39 GMT

Calcutta Telegraph

Ranbaxy, Orchid enter alliance; Ranbaxy Q1 PAT down 10%
Economic Times, India - Apr 22, 2008
MUMBAI: Ranbaxy Laboratories Ltd and Orchid Chemicals & Pharmaceuticals Ltd have entered into a business alliance agreement involving multiple geographies ...
India's Ranbaxy Laboratories and Orchid Chemicals in tie up Forbes
Mkts: Ultratech rises on strong results @ 14:32 hrs Sify
Ranbaxy Laboratories sees 7% net profit lift in Q1FY09 Financial Express
International Herald Tribune - Bloomberg
all 75 news articles

Tue, 15 Apr 2008 09:51:18 GMT

Wall Street Journal Blogs

Ranbaxy to sell ulcer drug Nexium in US
Economic Times, India - Apr 15, 2008
15 Apr, 2008, 1507 hrs IST, PTI NEW DELHI: Ranbaxy Pharmaceuticals Inc, a wholly-owned subsidiary of Ranbaxy Laboratories Ltd, has announced that it has ...
Out of the Gate: AstraZeneca Rises CNNMoney.com
Ranbaxy in several agreement with Astrazeneca India Infoline.com
Ranbaxy, AstraZeneca settle Nexium suit NDTV.com
Wall Street Journal - Bloomberg
all 215 news articles

Tue, 22 Apr 2008 18:28:22 GMT

Hindu Business Line

Ranbaxy first quarter net rises 7.2% at Rs 153 cr
Hindu Business Line, India - Apr 22, 2008
Mr Malvinder Mohan Singh, CEO & Managing Director, Ranbaxy Laboratories Ltd, and Mr Omesh Sethi, Vice-President & Finance Head, at a press conference in the ...

Fri, 25 Apr 2008 12:39:17 GMT

TopNews

Ranbaxy gets FDA nod for cetirizine HCL
Reuters India, India - Apr 25, 2008
MUMBAI (Reuters) - Drug maker Ranbaxy Laboratories Ltd said on Friday it had received approval from the US Food and Drug Administration for cetirizine ...
India's Ranbaxy receives US FDA approval to make, market allergy ... Forbes
Ranbaxy gets nod to market Cetirizine in US Economic Times
Ranbaxy set to market drugs in the US Business Standard
TopNews - Trading Markets (press release)
all 21 news articles

Tue, 15 Apr 2008 18:09:26 GMT

TopNews

Open offer hopes buoy Orchid
Hindu Business Line, India - Apr 15, 2008
Ranbaxy Laboratories has 15.63 per cent weight in the Sensex. In the recent past, Ranbaxy has picked up equity in Zenotech Laboratories Ltd, ...
Morgan Stanley raises stake in India's Orchid Chemicals MarketWatch
Orchid Chemicals sees block deals for 1.76 pct equity Reuters India
Orchid still in bloom on takeover buzz Livemint
Business Standard - Hindu Business Line
all 39 news articles

Tue, 06 May 2008 23:41:50 GMT

Teva seeks judgment on Astra's Nexium patents
Reuters - May 6, 2008
Teva, which could not be reached for comment, is the second generic to challenge Nexium after India's Ranbaxy Laboratories Ltd (RANB. ...

Wed, 30 Apr 2008 13:28:13 GMT

The Money Times

Pfizer says US confirms patent on cholesterol drug Lipitor
BusinessWeek - Apr 30, 2008
The Patent Office had conducted a re-examination of the patent in response to a request by Indian generic drugmaker Ranbaxy Laboratories Ltd. The patent ...
Pfizer:Patentability Of Lipitor Basic Patent To Be Confirmed CNNMoney.com
Pfizer: US govt to confirm 'patentability' of Lipitor basic patent ... Forbes
Pfizer says US confirms patent on Lipitor Reuters
Trading Markets (press release)
all 24 news articles

Directory | Disclaimer

Developed by WorldITLab.

Content by Stock Market Guide